Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Surgical Endoscopy
Published in: Surgical Endoscopy 2/2006

01-02-2006

Histologic and clinical outcome after laparoscopic Nissen fundoplication for gastroesophageal reflux disease and Barrett’s esophagus

Authors: V. Ozmen, E. Sen Oran, E. Gorgun, O. Asoglu, A. Igci, M. Kecer, F. Dizdaroglu

Published in: Surgical Endoscopy | Issue 2/2006

Login to get access

Abstract

Background

The effectiveness of laparoscopic Nissen fundoplication for the regression of Barrett’s esophagus in gastroesophageal reflux disease remains controversial. The aim of this study, therefore, was to review endoscopic findings and clinical changes after laparoscopic Nissen fundoplication for gastroesophageal reflux disease, particularly for patients with Barrett’s esophagus.

Methods

From September 1995 through June 2004, 127 patients with gastroesophageal reflux disease underwent laparoscopic Nissen fundoplication. All the patients had clinical and endoscopic follow-up evaluation. We further analyzed the course of 37 consecutive patients with Barrett’s esophagus (29% of all laparoscopic fundoplications performed in our institution) using endoscopic surveillance with appropriate biopsies and histologic evaluation. The median follow-up period for all the patients after fundoplication was 34 months (range, 3–108 months). The median follow-up period for the patients with Barrett’s esophagus was 19 months (range, 3–76 months).

Results

During the 9-year period, 70 women (55 %) and 57 (45%) men were treated with laparoscopic Nissen fundoplication. The median age of these patients was 42 years (range, 7–81 years). The clinical results were considered excellent for 67 patients (53%), good for 51 patients (40%), fair for 7 patients (6%), and poor for 2 patients (1%). Endoscopic surveillance showed regression of the macroscopic columnar segment in 23 patients with Barrett’s esophagus (62%). Regression at a histopathologic level occurred for 15 patients (40%). The histopathology remained unchanged for 14 patients with Barrett’s esophagus (38%).

Conclusion

Laparoscopic Nissen fundoplication effectively controls intestinal metaplasia and clinical symptoms in the majority of patients with Barrett’s esophagus.
Literature
1.
Armstrong D, Bennett JR, Blum AL, Dent J, De Dombal FT, Galmiche JP, Lundell L, Margulies M, Richter JE, Spechler SJ, Tytgat GN, Wallin L (1996) The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 111: 85–92CrossRefPubMed
2.
Corder AP, Jones RH, Sadler GH, Daniels P, Johnson CD (1996) Heartburn, esophagitis, and Barrett’s esophagus in self-medicating patients in general practice. Br J Clin Pract 50: 245–248PubMed
3.
Csendes A, Braghetto I, Burdiles P, Puente G, Korn O, Diaz JC, Maluenda F (1998) Long-term results of classic antireflux surgery in 152 patients with Barrett’s esophagus: clinical, radiologic, endoscopic, manometric, and acid reflux test analysis before and late after operation. Surgery 123: 645–657PubMed
4.
Csendes A, Smok G, Burdiles P, Quesada F, Huertas C, Rojas J, Korn O (2000) Prevalence of Barrett’s esophagus by endoscopy and histologic studies: a prospective evaluation of 306 control subjects and 376 patients with symptoms of gastroesophageal reflux. Dis Esophagus 13: 5–11PubMed
5.
DeMeester SR, Campos GM, DeMeester TR, Bremner CG, Hagen JA, Peters JH, Crookes PF (1998) The impact of an antireflux procedure on intestinal metaplasia of the cardia. Ann Surg 228: 547–556CrossRefPubMed
6.
DeVault KR, Castell DO (2005) Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 100: 190CrossRefPubMed
7.
Eubanks TR, Omelanczuk P, Richards C, Pohl D, Pellegrini CA (2000) Outcomes of laparoscopic antireflux procedures. Am J Surg 179: 391—395CrossRefPubMed
8.
Frantzides CT, Carlson MA, Madan AK, Stewart ET, Smith C (2003) Selective use of esophageal manometry and 24-hour pH monitoring before laparoscopic fundoplication. J Am Coll Surg 197: 358–363PubMed
9.
Gurski RR, Peters JH, Hagen JA, DeMeester SR, Bremner CG, Chandrasoma PT, DeMeester TR (2003) Barrett’s esophagus can and does regress after antireflux surgery: a study of prevalence and predictive features. J Am Coll Surg 196: 706–713CrossRefPubMed
10.
Hofstetter WL, Peters JH, DeMeester TR, Hagen JA, DeMeester SR, Crookes PF, Tsai P, Banki F, Bremner CG (2001) Long-term outcome of antireflux surgery in patients with Barrett’s esophagus. Ann Surg 234: 532–539CrossRefPubMed
11.
Lundell L, Miettinen P, Myrvold HE, Pedersen SA, Liedman B, Hatlebakk JG, Julkonen R, Levander K, Carlsson J, Lamm M, Wiklund I (2001) Continued (5-year) follow-up of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease. J Am Coll Surg 192: 172–181PubMed
12.
Oelschlager BK, Barreca M, Chang L, Oleynikov D, Pellegrini C (2003) Clinical and pathologic response of Barrett’s esophagus to laparoscopic antireflux surgery. Ann Surg 238: 458–466PubMed
13.
Patti MG, Diener U, Tamburini A, Molena D, Way LW (2001) Role of esophageal function tests in diagnosis of gastroesophageal reflux disease. Dig Dis Sci 46: 597–602CrossRefPubMed
14.
Richter JE (2001) Antireflux surgery and adenocarcinoma of the esophagus: let the truth be told. Gastroenterology 121: 1506–1508PubMed
15.
Ritter DW, Vanderpool D, Westmoreland M (1997) Laparoscopic Nissen fundoplication for gastroesophageal reflux disease. Am J Surg 174: 715–718CrossRefPubMed
16.
Rossetti M, Hell K (1977) Fundoplication for the treatment of gastroesophageal reflux in hiatal hernia. World J Surg 1: 439—443CrossRefPubMed
17.
Takeyama S, Numata A, Nenohi M, Shibata Y, Okushiba S, Katoh H (2004) Laparoscopic Nissen fundoplication for gastroesophageal reflux disease in Japan. Surg Today 34: 506–509CrossRefPubMed
18.
Winters C, Jr., Spurling TJ, Chobanian SJ, Curtis DJ, Esposito RL, Hacker JF, Johnson DA 3rd, Cruess DF, Cotelingam JD, Gurney MS (1987) Barrett’s esophagus: a prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 92: 118–124PubMed
19.
Yau P, Watson DI, Devitt PG, Game PA, Jamieson GG (2000) Laparoscopic antireflux surgery in the treatment of gastroesophageal reflux in patients with Barrett esophagus. Arch Surg 135: 801–805PubMed
Metadata
Title
Histologic and clinical outcome after laparoscopic Nissen fundoplication for gastroesophageal reflux disease and Barrett’s esophagus
Authors
V. Ozmen
E. Sen Oran
E. Gorgun
O. Asoglu
A. Igci
M. Kecer
F. Dizdaroglu
Publication date
01-02-2006
Publisher
Springer-Verlag
Published in
Surgical Endoscopy / Issue 2/2006
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-005-0434-9

Other articles of this Issue 2/2006

Surgical Endoscopy 2/2006 Go to the issue

OriginalPaper

Relationship between subjective and objective outcome measures after Heller myotomy and Dor fundoplication for achalasia

OriginalPaper

Electrical stimulation for gastroparesis

OriginalPaper

Early U.S. outcomes of laparoscopic gastric bypass versus laparoscopic adjustable silicone gastric banding for morbid obesity

OriginalPaper

Immediate preoperative laparoscopic staging for squamous cell carcinoma of the esophagus

Editorial

Introduction to NOTES White Paper

OriginalPaper

Experience with minimally invasive esophagectomy